Delivering next-generation treatments for back of the eye disorders, with focus on diabetic eye disease

Our mission

Our goal is to prevent vision loss and fight blindness worldwide by developing and delivering next-generation treatments in ophthalmology. We aim to lower the burden of treatment for patients and enhance practice management for physicians.

We develop innovative compounds that each target a distinct, unexplored pathway to answer unmet medical needs in ophthalmology, with a focus on back of the eye disease.

Our current pipeline of unique drug candidates is focused on new treatment approaches for diabetic eye disease, and we will continue leveraging our expertise in diseases affecting the back of the eye to expand our pipeline to address additional indications with high unmet needs.

We are committed to innovation through cross-disciplinary and cooperative research across the globe. Collaborating with stakeholders worldwide, we aim to deliver solutions enabling equal, affordable vision preservation for all people.